Medical Innovations

Insulin Nasal Spray Could Delay Cognitive Function Decline

1 Mins read



Studies have shown that insulin levels are lower in the central nervous systems of Alzheimer’s patients. A new study suggests that restoring insulin levels through the use of insulin nasal spray could delay the decline of cognitive function in those with Alzheimer’s and mild cognitive impairment.
Investigators from the University of Washington School of Medicine assigned 104 participants with certain types of mild cognitive impairment or Alzheimer’s disease into three groups. Over a period of four months, one group received 20 international units of insulin nasal spray per day, one group received 40 IUs and the remaining third received a placebo.

The results showed improved cognition and cerebral glucose metabolism in the insulin-receiving participants prompting the call for further study. Ask your physician.

Related posts
Medical InnovationsSpecialtiesTechnology

Deciphering the Controversy of Adipose Derived Stem Cells in the Context of Healthcare

4 Mins read
As we enter a new era of medical advancements, several new techniques in medicine have been pioneered. You may have heard of…
Medical InnovationsTechnology

5 AI Hotspots In Medicine To Know About

3 Mins read
Medicine moves slowly — until it doesn’t. Sometimes, a technology like CRISPR comes along that changes the treatment landscape for dozens of…
Medical InnovationsTechnology

How Medical Prototyping Is Revolutionizing The Way Medicine Is Practiced

5 Mins read
Innovations and advancements in precision machining have made CNC machining and rapid prototyping essential methods in the production of life-saving medical devices….